Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia

ConclusionsIndirect comparison of alternative azacitidine dosing regimens in MDS and AML shows a benefit for the 7-day regimen in attaining ORR. Additional RCTs are required to definitively address this comparison.

Source: BMC Hematology - January 31, 2018 Category: Hematology Source Type: research